Prevalence and Risk Factors of Low Anterior Resection Syndrome in Epithelial Ovarian Cancer Surgery
- PMID: 35444906
- PMCID: PMC9009365
- DOI: 10.7759/cureus.23180
Prevalence and Risk Factors of Low Anterior Resection Syndrome in Epithelial Ovarian Cancer Surgery
Abstract
Background In this study, we aimed to determine the prevalence and risk factors of low anterior resection syndrome (LARS) in epithelial ovarian cancer (EOC) surgery. Methodology A descriptive cross-sectional study was conducted at the Gynecologic Oncology Section of the Department of Surgical Oncology, Shaukat Khanum Memorial Cancer Hospital & Research Centre, Lahore, Pakistan. Using non-probability consecutive sampling technique, all patients who underwent cytoreductive surgery involving low anterior resection for EOC between January 2016 and January 2021 were included. Patients were assessed for LARS symptoms using the LARS score, along with its risk factors. Descriptive statistics, that is, continuous variables were expressed as the median and interquartile range, while categorical variables were expressed as frequencies and percentages. The LARS score was categorized according to a two-tier model with "no or minor LARS" and "major LARS." Univariate analyses were performed by the chi-square tests providing odds ratios and 95% confidence intervals to identify risk factors for major LARS. Results Overall, 95% of cases had LARS scores that fell in "no or minor LARS," while only 5% of cases had "major LARS." Univariate analyses relieved no statistically significant association between the occurrence of major LARS and any of the risk factors. Conclusions The prevalence of LARS was 5%, and no risk factors were associated with major LARS in our study population.
Keywords: epithelial ovarian cancer; gynecologic oncology; low anterior resection; low anterior resection syndrome; ovarian cancer surgery.
Copyright © 2022, Yasin et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
Low anterior resection syndrome (LARS) in patients with epithelial ovarian cancer after primary debulking surgery.Gynecol Oncol. 2019 Sep;154(3):577-582. doi: 10.1016/j.ygyno.2019.06.015. Epub 2019 Jun 21. Gynecol Oncol. 2019. PMID: 31235241
-
Factors determining low anterior resection syndrome after rectal cancer resection: A study in Thai patients.Asian J Surg. 2016 Oct;39(4):225-31. doi: 10.1016/j.asjsur.2015.07.003. Epub 2015 Sep 2. Asian J Surg. 2016. PMID: 26340884
-
Is the interval from surgery to ileostomy closure a risk factor for low anterior resection syndrome?Colorectal Dis. 2017 May;19(5):485-490. doi: 10.1111/codi.13524. Colorectal Dis. 2017. PMID: 27634544
-
Sacral nerve stimulation for bowel dysfunction following low anterior resection: a systematic review and meta-analysis.Colorectal Dis. 2019 Nov;21(11):1240-1248. doi: 10.1111/codi.14690. Epub 2019 Jun 13. Colorectal Dis. 2019. PMID: 31081580
-
Treatment possibilities for low anterior resection syndrome: a review of the literature.Int J Colorectal Dis. 2018 Mar;33(3):251-260. doi: 10.1007/s00384-017-2954-x. Epub 2018 Jan 8. Int J Colorectal Dis. 2018. PMID: 29313107 Review.
References
-
- Cancer statistics, 2022. Siegel RL, Miller KD, Fuchs HE, Jemal A. CA Cancer J Clin. 2022;72:7–33. - PubMed
-
- The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status. Gohagan JK, Prorok PC, Hayes RB, Kramer BS. Control Clin Trials. 2000;21:251–272. - PubMed
-
- Prognostic impact of debulking surgery and residual tumor in patients with epithelial ovarian cancer FIGO stage IV. Ataseven B, Grimm C, Harter P, Heitz F, Traut A, Prader S, du Bois A. Gynecol Oncol. 2016;140:215–220. - PubMed
-
- Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d'Investigateurs Nationaux Pour les Etudes des Cancers de l'Ovaire (GINECO) du Bois A, Reuss A, Pujade-Lauraine E, Harter P, Ray-Coquard I, Pfisterer J. Cancer. 2009;115:1234–1244. - PubMed
LinkOut - more resources
Full Text Sources